We are live on ! Find out more
ZDA

Zweig-DiMenna Associates Portfolio holdings

AUM $1.1B Turnover 40.24%
1-Year Est. Return 171.86%
This Fund
S&P 500
This Quarter Est. Return
-8.15%
1 Year Est. Return
+171.86%
3 Year Est. Return
+561.39%
5 Year Est. Return
+872.04%
10 Year Est. Return
+5,051.75%
AUM
$2.31B
AUM Growth
+$497M
Cap. Flow
+$552M
Cap. Flow %
23.92%
Top 10 Hldgs %
30.83%
Holding
324
New
77
Increased
76
Reduced
52
Closed
107
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.5 years
Top 20 Avg Time Held Equity + Options
0.5 years
Avg Time Held Equity only
0.8 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.5 years

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$90.9M
2
AGN
Allergan plc
AGN
+$50.4M
3
CELG
Celgene Corp
CELG
+$48.9M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$40M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$39.2M

Top Sells

Rank Stock Value
1
BHI
Baker Hughes
BHI
+$34.4M
2
BABA icon
Alibaba
BABA
+$25M
3
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
+$23.5M
4
BA icon
Boeing
BA
+$19.8M
5
AMAT icon
Applied Materials
AMAT
+$18.9M

Sector Composition

Rank Sector Weight
1 Healthcare 23.93%
2 Consumer Discretionary 12.92%
3 Miscellaneous 11.57%
4 Communication Services 10.21%
5 Technology 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
RIG icon
1
PUT
Transocean
RIG
$6.13B
$178M 7.71%
13,780,000
+12,580,000
+1,048% +$175M
2014 Q4
3 quarters
BHI
2
DELISTED
Baker Hughes
BHI
$111M 4.79%
2,123,584
-616,802
-23% -$34.4M
2014 Q4
3 quarters
BMY icon
3
Bristol-Myers Squibb
BMY
$126B
$85.5M 3.7%
1,443,723
+1,433,653
+14,237% +$90.9M
2015 Q1
2 quarters
AGN
4
DELISTED
Allergan plc
AGN
$72.8M 3.15%
267,660
+164,040
+158% +$50.4M
2014 Q1
6 quarters
HCA icon
5
HCA Healthcare
HCA
$103B
$48.7M 2.11%
630,011
+325,726
+107% +$28.8M
2013 Q4
7 quarters
V icon
6
Visa
V
$746B
$45.7M 1.98%
655,632
+32,872
+5% +$2.35M
2013 Q2
9 quarters
GOOG icon
7
Alphabet (Google) Class C
GOOG
$4.23T
$45.1M 1.95%
1,447,180
+150,280
+12% +$4.62M
2013 Q2
9 quarters
CELG
8
DELISTED
Celgene Corp
CELG
$42.6M 1.85%
+394,282
New +$48.9M
2015 Q3
0 quarters
AMZN icon
9
Amazon
AMZN
$2.71T
$41.8M 1.81%
1,634,880
+711,360
+77% +$18M
2015 Q1
2 quarters
META icon
10
Meta Platforms (Facebook)
META
$1.87T
$41.3M 1.79%
459,718
+25,860
+6% +$2.37M
2013 Q2
9 quarters
BKNG icon
11
Booking.com
BKNG
$123B
$41.3M 1.79%
834,400
-7,300
-0.9% -$363K
2013 Q2
9 quarters
TWX
12
DELISTED
Time Warner Inc
TWX
$40.4M 1.75%
587,440
-71,735
-11% -$5.63M
2014 Q3
4 quarters
VRTX icon
13
Vertex Pharmaceuticals
VRTX
$129B
$35.2M 1.53%
338,441
+311,441
+1,153% +$40M
2014 Q2
5 quarters
ALXN
14
DELISTED
Alexion Pharmaceuticals
ALXN
$33.6M 1.46%
+214,946
New +$39.2M
2015 Q3
0 quarters
BHC icon
15
Bausch Health
BHC
$2.29B
$33.3M 1.44%
186,798
+42,071
+29% +$9.81M
2015 Q1
2 quarters
DHR icon
16
Danaher
DHR
$160B
$32.4M 1.4%
565,160
+37,926
+7% +$2.24M
2014 Q4
3 quarters
BMRN icon
17
BioMarin Pharmaceuticals
BMRN
$11B
$31.2M 1.35%
296,065
+243,565
+464% +$32.5M
2013 Q2
9 quarters
APC icon
18
DELISTED
Anadarko Petroleum
APC
$30M 1.3%
495,997
+41,573
+9% +$2.95M
2014 Q2
5 quarters
SEE icon
19
DELISTED
Sealed Air
SEE
$29.6M 1.28%
630,657
+151,778
+32% +$7.84M
2013 Q2
9 quarters
WBA icon
20
DELISTED
Walgreens Boots Alliance
WBA
$29.4M 1.27%
+353,698
New +$32M
2015 Q3
0 quarters
BERY icon
21
DELISTED
Berry Global Group, Inc.
BERY
$28.5M 1.24%
1,033,508
+358,390
+53% +$10.3M
2014 Q1
6 quarters
DATA
22
DELISTED
Tableau Software, Inc.
DATA
$28.2M 1.22%
+353,748
New +$36.7M
2015 Q3
0 quarters
AAPL icon
23
Apple
AAPL
$5.04T
$27.8M 1.21%
1,009,756
+114,756
+13% +$3.37M
2013 Q2
9 quarters
SCU
24
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$27.4M 1.19%
313,576
+77,697
+33% +$8.36M
2013 Q2
9 quarters
HLT icon
25
Hilton Worldwide
HLT
$75.4B
$27.2M 1.18%
394,757
-51,219
-11% -$3.96M
2013 Q4
7 quarters
1
2 3 4 5

Similar funds

NW
Naviter Wealth Little Rock, Arkansas $1.1B AUM 33.28% 1-Year Est. Return
TFA
Teamwork Financial Advisors San Antonio, Texas $1.1B AUM 39.98% 1-Year Est. Return
TPA
Trivium Point Advisory Westport, Connecticut $1.1B AUM 28.81% 1-Year Est. Return
RA
Rodgers & Associates Lancaster, Pennsylvania $1.1B AUM 20.77% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
HBCM
Heron Bay Capital Management Bloomfield Hills, Michigan $1.1B AUM 11.31% 1-Year Est. Return
PFM
Premier Fund Managers Guildford, United Kingdom $1.1B AUM 14.42% 1-Year Est. Return
DI
DUMAC Inc Durham, North Carolina $1.1B AUM

Zweig-DiMenna Associates's Q3 2015 Portfolio in Review

As of Q3 2015, Zweig-DiMenna Associates held 324 positions worth $2.31B, up 27% from $1.81B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Zweig-DiMenna Associates deployed $552M of net new capital in Q3 2015, opening 77 new positions and adding to 76 existing holdings. Its largest new stake was Celgene Corp: 394,282 shares worth $42.6M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Miscellaneous.

On the sell side, the largest reduction was Baker Hughes, an estimated $34.4M trimmed.

  • Zweig-DiMenna Associates's largest Q3 2015 buy was Celgene Corp: 394,282 shares worth $42.6M.
  • Zweig-DiMenna Associates added most to Bristol-Myers Squibb in Q3 2015, an estimated $90.9M increase.
  • Zweig-DiMenna Associates's biggest Q3 2015 reduction was Baker Hughes, cutting an estimated $34.4M.
  • Zweig-DiMenna Associates fully exited Alibaba in Q3 2015, selling an estimated $25M.
  • Zweig-DiMenna Associates's ten largest holdings make up 31% of its $2.31B portfolio in Q3 2015.
  • Zweig-DiMenna Associates opened 77 new positions and closed 107 in Q3 2015.
  • Zweig-DiMenna Associates's portfolio value rose 27% quarter-over-quarter to $2.31B.

Based on Zweig-DiMenna Associates's 13F filing for Q3 2015, filed 9 Nov 2015.